Revvity is a global leader in developing and delivering technologies and solutions across disease pathways, focused on advancing health science and human potential. They develop cutting-edge technologies in areas like biomarker identification, multi-omics, diagnostics, and informatics, supporting critical processes from disease research to diagnostics and treatment. Serving over 2 million scientists and operating in 190 countries, Revvity aims to accelerate scientific breakthroughs that address significant health challenges.

“Great Is the Work That Remains”: Lady Cherie Blair on Why the Fight for 50:50 Representation is Far from Over
At Speaker’s House, human rights lawyer and campaigner Lady Cherie Blair KC made an impassioned case for urgent action to achieve gender equality in politics – reminding us all that progress is not guaranteed, and the work must continue.








